Evidence map›Paper›PMID 36363017›Full record

ArticleMaterials (Basel, Switzerland)2022

Covalent Organic Framework (C

Mohammed A Alkhalifah, Muhammad Yar, Imene Bayach, Nadeem S Sheikh, Khurshid Ayub

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Density functional theory (DFT), molecular docking, and xanthine oxidase inhibitory studies of dinaphthodiospyrol S fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  7. Article
  8. Covalent Triazine Framework CNanomaterials (Basel, Switzerland) · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Mohammed A AlkhalifahDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Muhammad YarDepartment of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, KPK, Pakistan.
Imene BayachDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Nadeem S SheikhChemical Sciences, Faculty of Science, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong BE1410, Brunei.ORCID 0000-0002-0716-7562
Khurshid AyubDepartment of Chemistry, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, KPK, Pakistan.
COMSATS University Islamabad · PKKing Faisal University · SAUniversiti Brunei Darussalam · BN

Funding

King Faisal University 1234
6 · The paper itself

Abstract

Continuous studies are being carried out to explore new methods and carrier surfaces for target drug delivery. Herein, we report the covalent triazine framework C

Indexed as

cancercovalent triazine framework C6N6density functional theorydrug delivery

Identifiers

PMID36363017
PMCPMC9654209
OpenAlexW4307262104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.